| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Strongbridge Biopharma plc | 10,000 | 48,000 | 0.01% | ||
| 2 | SEASPINE HLDGS CORP COM | 88,127 | 692,000 | 0.07% | ||
| 3 | BIOLASE INC | 1,261,287 | 1,703,000 | 0.18% | ||
| 4 | ADMA BIOLOGICS, INC. | 1,273,933 | 6,217,000 | 0.65% | ||
| 5 | ANI PHARMACEUTICALS INC | 143,003 | 7,080,000 | 0.74% | ||
| 6 | VERICEL CORP | 2,982,940 | 8,352,000 | 0.88% | ||
| 7 | ARRAY BIOPHARMA INC | 1,373,471 | 12,279,000 | 1.29% | ||
| 8 | ACORDA THERAPEUTICS INC | 619,419 | 13,008,000 | 1.36% | ||
| 9 | ACADIA COMPANY COM | 310,666 | 13,545,000 | 1.42% | ||
| 10 | CORINDUS VASCULAR ROBOTICS INCORPORATED | 15,114,872 | 19,800,000 | 2.08% | ||
| 11 | NOVADAQ TECHNOLOGIES INC | 3,018,179 | 23,512,000 | 2.46% | ||
| 12 | RETROPHIN INC | 2,132,140 | 39,359,000 | 4.13% | ||
| 13 | LA JOLLA PHARMACEUTICAL CO | 1,420,742 | 42,409,000 | 4.44% | ||
| 14 | PACIRA PHARMACEUTICALS INC | 972,535 | 44,348,000 | 4.65% | ||
| 15 | ADVANCED ACCELERATOR APPLIC | 1,311,855 | 52,291,000 | 5.48% | ||
| 16 | ATRICURE INC | 2,886,354 | 55,274,000 | 5.79% | ||
| 17 | CORCEPT THERAPEUTICS INC | 5,169,640 | 56,659,000 | 5.94% | ||
| 18 | MYRIAD GENETICS INC | 2,976,356 | 57,146,000 | 5.99% | ||
| 19 | MALLINCKRODT PUB LTD CO | 1,558,944 | 69,482,000 | 7.28% | ||
| 20 | AMARIN CORP PLC | 25,052,380 | 80,168,000 | 8.40% | ||
| 21 | CLOVIS ONCOLOGY INC | 1,334,467 | 84,966,000 | 8.91% | ||
| 22 | GLOBUS MED INC | 2,935,000 | 86,935,000 | 9.11% | ||
| 23 | UNITED THERAPEUTICS CORP DEL | 642,168 | 86,937,000 | 9.11% | ||
| 24 | HORIZON PHARMA PLC | 6,218,903 | 91,915,000 | 9.63% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-17-001278, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
